Onteveros, Imelda P.
HRN: 25-18-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2024
LEVOFLOXACIN 500MG (TAB)
06/14/2024
06/20/2024
ORAL
500mg
OD
Nephrolithiasis; T/c Urolithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes